MP66-01 RNA-SEQUENCING OF BCG TREATED BLADDER CANCER PATIENTS IDENTIFIES PATIENTS WITH AGGRESSIVE AND IMMUNE SUPPRESSIVE TUMORS AT RISK OF BCG FAILURE

Autor:	Tahlita C.M. Zuiverloon, Sébastien Rinaldetti, Ellen C. Zwarthoff, James C. Costello, Joep J. de Jong, Dan Theodorescu, Robert F. Hoedemaeker, Teemu D. Laajala, Angelique C. van der Made, Egbert R. Boevé, Florus C. de Jong, Jolien T. M. Mensink, Joost L. Boormans, Deric K. Van der Schoot
Rok vydání:	2021
Předmět:	Oncology Bacillus (shape) medicine.medical_specialty Bladder cancer biology business.industry Urology RNA Treatment options Disease medicine.disease biology.organism_classification Immune system Internal medicine Medicine Bcg failure business
Zdroj:	Journal of Urology. 206
ISSN:	1527-3792 0022-5347
DOI:	10.1097/ju.0000000000002106.01
Popis:	INTRODUCTION AND OBJECTIVE:Intravesical Bacillus Calmette-Guerin (BCG) is the recommended treatment option in high-risk non-muscle invasive bladder cancer (HR-NMIBC). However, disease recurrence oc...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::fc287759ac399e12a07c67e98fec3f40 https://doi.org/10.1097/ju.0000000000002106.01 Zobrazit plný text záznamu